• DefiniGEN Appoints Dr Chris Kirton as Chief Executive Officer 1/21/2022
• DefiniGEN Appoints Dr Ben Cons as Chairman of its Board 4/30/2021
• DefiniGEN Launches Tool for Coronavirus-specific Intestinal Cell Research 5/15/2020